| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 1,960,000 | 971,000 | 2,554,000 | 1,647,000 | | Cost of Revenue | 595,000 | 1,363,000 | 359,000 | 364,000 | | | Gross Profit | 1,365,000 | (392,000) | 2,195,000 | 1,283,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 129,000 | (415,000) | 407,000 | 346,000 | | Non Recurring | (43,000) | 1,000 | 1,000 |
-
| | Others | 62,000 | (847,000) | 965,000 | 56,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,217,000 | 869,000 | 822,000 | 881,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 19,000 | 505,000 | 35,000 | | Earnings Before Interest And Taxes | 1,224,000 | 888,000 | 1,327,000 | 917,000 | | Interest Expense | 16,000 | 25,000 | 30,000 | 30,000 | | Income Before Tax | 1,208,000 | 863,000 | 1,297,000 | 887,000 | | Income Tax Expense | 445,000 | 349,000 | 568,000 | 352,000 | | Minority Interest |
-
|
-
|
-
| 1,000 | | | | Net Income From Continuing Ops | 763,000 | 514,000 | 729,000 | 536,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 763,000 | 514,000 | 729,000 | 536,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $763,000 | $514,000 | $729,000 | $536,000 |
|
1.52% Nasdaq 
Income Statement
